Position in NVS
as of Jun 30, 2026
· filed Jul 24, 2026
Position Value
$208,594
+$5,284 QoQ
Shares Held
1,331
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.07%
of 13F equity value
Holder Rank
#1,297
of 1,603 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026KPP Advisory Services LLC holds $13,310,017 across 9 Drug Manufacturers - General names. NVS ranks #9 (1.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
2,871 | $3,443,563 | |
| 2 | JNJ |
Johnson & Johnson
|
13,304 | $3,378,816 | |
| 3 | ABBV |
AbbVie Inc.
|
9,796 | $2,465,065 | |
| 4 | AMGN |
Amgen Inc
|
5,655 | $2,047,788 | |
| 5 | MRK |
Merck & Co., Inc.
|
6,862 | $881,767 | |
| 6 | PFE |
Pfizer Inc
|
15,236 | $366,882 | |
| 7 | GILD |
Gilead Sciences, Inc.
|
2,175 | $274,789 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,213 | $242,753 |
All Filings in NVS
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $208,594 | 1,331 | Shares | Sole | 2026-07-24 | |
| 2026-03-31 | $203,310 | 1,331 | Shares | Sole | 2026-04-24 | |
| No filing history on record for this holder in this stock. | ||||||